The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Catalyst Pharmaceuticals, Inc(NASDAQ:CPRX) 
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, a proprietary form of amifampridine phosphat...
Website: http://www.catalystpharma.com
Founded: 2002
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology
Catalyst Pharmaceuticals Days Payable Outstanding ttm (DPO)
Catalyst Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Catalyst Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Catalyst Pharmaceuticals Op Cashflow Per Share ttm
Catalyst Pharmaceuticals Free Cashflow Per Share ttm
Catalyst Pharmaceuticals Cash Per Share ttm
Catalyst Pharmaceuticals P/S ratio ttm
Catalyst Pharmaceuticals (GAAP) P/E ratio ttm
Catalyst Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.